Explore approaches to improve internal review processes for new investigator-initiated studies, determine fair market value, and manage the study lifecycle while staying compliant with current regulations. Diverse panels will compare the various methods used across different sized companies in specific therapeutic areas, and the positive and negative outcomes of these methods.

 Who Attends: Investigator-Initiated Research, Research Collaborations, Medical Affairs, Medical Operations, MSLs, Clinical Liaisons, and Research Grants Professionals